The application of thermodynamic methods in drug design

Thermochimica Acta

Volumn 380, Issue 2, 2001, Pages 217-227

  Velazquez Campoy, Adrian ^a   Luque, Irene ^a   Freire, Ernesto ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Binding affinity; Drug design; HIV 1 protease

Indexed keywords

PROTEINASE INHIBITOR;

ADAPTATION; ARTICLE; BINDING AFFINITY; BINDING SITE; CONFORMATION; DRUG DESIGN; DRUG RESISTANCE; ENTHALPY; ENTROPY; GENETIC POLYMORPHISM; HYDROPHOBICITY; MUTATION; THERMODYNAMICS;

EID: 0035861396     PISSN: 00406031     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-6031(01)00671-2     Document Type: Article

References (30)

1. The key-lock theory and the induced fit theory
2. Binding of small molecules to macromolecular targets: Evaluation of conformational entropy changes
3. The thermodynamic basis of resistance to HIV-1 protease inhibition. Calorimetric analysis of the V82F/I84V active site resistant mutant
4. Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease
5. Characterization of human immunodeficiency virus type 1 variants with increased resistant to a C2-symmetric protease inhibitor
6. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
7. Drug-resistance patterns of saquinavir and other HIV-1 proteinase inhibitors
8. Mutations in retroviral genes associated with drug resistance
9. Crystal structures of complexes of a peptidic inhibitor with wild-type and two mutant HIV-1 proteases
10. Molecular basis of HIV-1 protease drug resistance: Structural analysis of mutant proteases complexed with cyclic urea inhibitors
11. Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency agains both wild type and protease inhibitor resistant mutants of HIV
12. Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: Relationship to drug resistance
13. Structural basis of drug resistance for the V82F mutant of HIV-1 protease: Backbone flexibility and substrate repacking
14. Selection and analysis of human immunodeficiency, a novel protease inhibitor virus type 1 variants with increased resistance to ABT-538
15. Resistance to HIV-1 protease inhibitors: A comparison of enzyme inhibition and antiviral potency
16. Counteracting HIV-1 protease drug resistance: Structural analysis of mutant proteases complexed with XV638 and SD146, cyclic urea amides with broad specificities
17. The molecular basis of resistance to HIV-1 protease inhibition: A plausible hypothesis
18. The effect of inhibitor binding on the structural stability and cooperativity of the HIV-1 protease
19. HIV-1 protease inhibitors: Enthalpic versus entropic optimization of the binding affinity
20. The enthalpy change in protein folding and binding. Refinement of parameters for structure-based calculations
21. The propagation of binding interactions to remote sites in proteins. Analysis of the binding of the monoclonal antibody D1.3 to lysozyme
22. The structural stability of binding sites. Consequences for binding affinity and cooperativity
23. Thermodynamic dissection of the binding energetics of KNI-272: A powerful HIV-1 protease inhibitor protein
24. Evaluation of linked protonation effects in protein binding using isothermal titration calorimetry
25. Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere
26. Design and synthesis of a covalently linked HIV-1 protease dimer analog and peptidomimetic inhibitors
27. Small dipeptide-based HIV-1 protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition state mimic
28. Structure-activity relationship of small-sized HIV-1 protease inhibitors containing allophenylnorstatine
29. Protein structure and the energetics of protein
30. The binding energetics of first- and second-generation HIV-1 protease inhibitors: Implications for drug design